This report details the possible involvement of Osteoprotegerin (OPG) in the prevention of AAAs through inhibition of Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The gene discussed is TNFSF10; the disease is achalasia-alacrima syndrome.